548
Views
13
CrossRef citations to date
0
Altmetric
Review

Therapeutic complement inhibition: a promising approach for treatment of neuroimmunological diseases

, , &
Pages 579-591 | Received 28 Jul 2016, Accepted 12 Jan 2017, Published online: 06 Mar 2017

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Nithi Asavapanumas, Lukmanee Tradtrantip & Alan S. Verkman. (2021) Targeting the complement system in neuromyelitis optica spectrum disorder. Expert Opinion on Biological Therapy 21:8, pages 1073-1086.
Read now
Paula Restrepo-Jiménez, Yhojan Rodríguez, Paulina González, Christopher Chang, M. Eric Gershwin & Juan-Manuel Anaya. (2018) The immunotherapy of Guillain-Barré syndrome. Expert Opinion on Biological Therapy 18:6, pages 619-631.
Read now

Articles from other publishers (11)

Jia Liu, Xi Shao, Jingya Fan, Ying Wang, Yuanbo Cao, Guojun Tan, Kazuo Sugimoto, Bin Li & Zhen Jia. (2023) Association of plasma sPD ‐1 and sPD‐L1 with disease status and future relapse in AQP4‐IgG (+) NMOSD . Annals of Clinical and Translational Neurology.
Crossref
Lucian Eva, Horia Pleș, Razvan-Adrian Covache-Busuioc, Luca Andrei Glavan, Bogdan-Gabriel Bratu, Andrei Bordeianu, David-Ioan Dumitrascu, Antonio Daniel Corlatescu & Alexandru Vlad Ciurea. (2023) A Comprehensive Review on Neuroimmunology: Insights from Multiple Sclerosis to Future Therapeutic Developments. Biomedicines 11:9, pages 2489.
Crossref
Nil Saez-Calveras & Olaf Stuve. (2022) The role of the complement system in Multiple Sclerosis: A review. Frontiers in Immunology 13.
Crossref
Yhojan Rodríguez, Lucas Restrepo, Christopher Chang & Juan-Manuel Anaya. 2022. Allergic and Immunologic Diseases. Allergic and Immunologic Diseases 887 975 .
Xu Liu, Yating Zhao, Na Guo, Dandan Tian, Ruixia Zhu & Jian Zhang. (2021) Field synopsis and systematic meta-analyses of genetic association studies in neuromyelitis optica. Autoimmunity Reviews 20:7, pages 102843.
Crossref
Clémence David, Benjamin Chaigne, Clémence Hollande, Benoit Terris, Pascal Cohen, Bertrand Dunogue, Benjamin Terrier, Philippe Sogni, Claire Goulvestre & Luc Mouthon. (2021) Primary biliary cholangitis and systemic sclerosis (Reynolds syndrome): A case–control study. Autoimmunity Reviews 20:7, pages 102842.
Crossref
Barbara Uzonyi, Zsóka Szabó, Eszter Trojnár, Satu Hyvärinen, Katalin Uray, Helle H. Nielsen, Anna Erdei, T. Sakari Jokiranta, Zoltán Prohászka, Zsolt Illes & Mihály Józsi. (2021) Autoantibodies Against the Complement Regulator Factor H in the Serum of Patients With Neuromyelitis Optica Spectrum Disorder. Frontiers in Immunology 12.
Crossref
Chuan Qin, Bo Chen, Ran Tao, Man Chen, Xue Ma, Ke Shang, Long-Jun Wu, Wei Wang, Bi-Tao Bu & Dai-Shi Tian. (2019) The clinical value of complement proteins in differentiating AQP4-IgG-positive from MOG-IgG-positive neuromyelitis optica spectrum disorders. Multiple Sclerosis and Related Disorders 35, pages 1-4.
Crossref
Sarah M. Carpanini, Megan Torvell & Bryan Paul Morgan. (2019) Therapeutic Inhibition of the Complement System in Diseases of the Central Nervous System. Frontiers in Immunology 10.
Crossref
Yhojan Rodríguez, Christopher Chang, Diana C. González-Bravo, M. Eric Gershwin & Juan-Manuel Anaya. 2019. Neuroimmune Diseases. Neuroimmune Diseases 711 736 .
Paulus S. Rommer, Michael Hecker, Tobias Zrzavy, Nina Boxberger & Uwe K. Zettl. 2019. Neuroimmune Diseases. Neuroimmune Diseases 387 421 .

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.